Ghasem Solgi | Microbiology | Best Researcher Award

Prof. Ghasem Solgi | Microbiology | Best Researcher Award

Professor of Immunology from Hamadan University of Medical Sciences, Iran

Dr. Ghasem Solgi is a seasoned medical immunologist with extensive experience in both academic and clinical research settings. Born in 1976 in Iran, he has dedicated over two decades to advancing the field of immunology, particularly in transplantation and immunogenetics. As the Head of the Immunogenetics Lab at Hamadan University of Medical Sciences, Dr. Solgi has played a pivotal role in shaping research in HLA-related immunology and autoimmune diseases. His research primarily investigates the role of HLA genes in disease susceptibility, treatment response, and transplant outcomes, contributing valuable insights to clinical immunology. Dr. Solgi’s leadership experience, including his tenure as Deputy for Research Affairs and Head of the Immunology Department, reflects his commitment to both scientific inquiry and academic governance. He has mentored numerous graduate and postgraduate students, actively participates in peer review for high-impact journals, and maintains membership in respected scientific societies. His multidisciplinary approach, which bridges immunogenetics, autoimmune diseases, and clinical transplant immunology, underscores the translational impact of his work. With an impressive history of scientific supervision and collaboration, Dr. Solgi continues to contribute to the global immunology community through both innovative research and the nurturing of future scholars.

Professional Profile

Education

Dr. Ghasem Solgi holds a strong academic foundation in medical immunology, shaped by rigorous training at renowned institutions. He earned his Ph.D. in Medical Immunology from Tehran University of Medical Sciences in 2009. His doctoral thesis focused on the effects of donor bone marrow cell infusion on microchimerism and allograft outcomes in kidney transplant patients, followed by a comprehensive five-year follow-up study—highlighting his early dedication to transplantation immunology. Prior to his doctoral studies, Dr. Solgi completed his M.Sc. in Medical Immunology at Isfahan University of Medical Sciences in 2002. His master’s thesis compared serological and DNA-based methods for HLA typing in kidney allograft recipients, laying the groundwork for his long-standing focus on HLA research. Further enriching his expertise, he undertook a practical course and thesis completion in Transplantation Immunology at IKT in Ulm, Germany, during 2008–2009. This international experience not only refined his technical skills but also exposed him to diverse scientific environments. Dr. Solgi’s educational trajectory demonstrates a consistent commitment to excellence in immunology, emphasizing both theoretical knowledge and hands-on laboratory experience. His academic preparation has been instrumental in shaping his career as a researcher, educator, and clinical immunology expert.

Professional Experience

Dr. Ghasem Solgi has accumulated a wealth of professional experience in academia and research since earning his doctoral degree. He currently serves as the Head of the Immunogenetics Lab in the Immunology Department at Hamadan University of Medical Sciences, a role he has held since 2020. From 2016 to 2020, he was the Deputy for Research Affairs of the Medical School, where he contributed to strategic planning and research development. Previously, between 2015 and 2019, he served as the Head of the Immunology Department at the same institution, reflecting his leadership capabilities and influence on departmental growth. Earlier in his career, Dr. Solgi worked as an Assistant Professor in the Immunology Department at Hamadan University (2012–2015) and Ahvaz Jundishapur University of Medical Sciences (2009–2012). These academic roles have allowed him to balance research, teaching, and mentorship, while advancing the university’s immunology programs. His career path demonstrates a steady progression of leadership in both scientific and administrative capacities. Through his sustained involvement in immunogenetics and autoimmune research, Dr. Solgi has cultivated a distinguished profile, earning respect from colleagues, students, and collaborators alike.

Research Interests

Dr. Ghasem Solgi’s research interests lie primarily in the field of immunogenetics and transplantation immunology, with a particular focus on the Human Leukocyte Antigen (HLA) system and its relationship to disease pathogenesis and therapeutic outcomes. His studies aim to understand how genetic and immunological factors influence immune responses in organ transplantation and autoimmune disorders. Specifically, he investigates the distribution of HLA alleles and haplotypes in diseases such as type 1 diabetes (T1D), multiple sclerosis (MS), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and their correlation with susceptibility, disease severity, and treatment response. Dr. Solgi has also examined the role of HLA in COVID-19, exploring genetic predisposition to disease severity. His transplantation research includes microchimerism analysis, anti-HLA antibody detection, and long-term survival of kidney transplant patients. These interdisciplinary topics combine clinical relevance with molecular insights, aiming to improve diagnosis, prognosis, and personalized treatment strategies. His dedication to integrating immunogenetic data with clinical outcomes has placed his research at the intersection of translational medicine and precision immunology. This comprehensive scope not only addresses pressing healthcare challenges but also contributes to evolving strategies in immunotherapy and transplant compatibility assessment.

Research Skills

Dr. Ghasem Solgi possesses a robust set of research skills that span molecular biology, immunogenetics, and clinical immunology. He has extensive expertise in HLA typing using both serological and DNA-based methods, which he applied early in his career and further developed through practical training in Germany. His technical proficiency includes flow cytometry, ELISA, PCR-based genotyping, and microchimerism analysis—essential tools for studying immune responses in transplant recipients and autoimmune patients. Dr. Solgi is skilled in study design, biostatistical analysis, and survival analysis, which are critical in assessing long-term patient outcomes in kidney transplantation. He is also experienced in conducting family-based genetic studies to evaluate allelic distribution in disease populations. His ability to integrate laboratory findings with clinical parameters demonstrates a high level of translational research competency. In addition, Dr. Solgi’s editorial contributions to numerous international journals reflect his critical appraisal skills and deep understanding of current scientific methodologies. His mentoring record further showcases his ability to transfer knowledge and guide complex research projects, making him not only a proficient investigator but also a collaborative academic leader in immunology and genetic research.

Awards and Honors

While specific awards are not explicitly listed in the available documentation, Dr. Ghasem Solgi’s professional trajectory and academic appointments reflect significant recognition and respect within the scientific community. His leadership roles—such as Head of the Immunogenetics Lab, Head of the Immunology Department, and Deputy for Research Affairs—demonstrate institutional trust and acknowledgment of his scientific contributions. Additionally, his long-standing memberships in prominent organizations such as the Iranian Society of Immunology and Allergy (since 2006) and the European Federation for Immunogenetics (since 2010) further signify professional standing. Dr. Solgi’s participation as a manuscript reviewer for more than a dozen respected journals, including Scientific Reports, Journal of Clinical Medicine, Human Immunology, and Diagnostics, underscores his expertise and influence in shaping contemporary immunological research. These editorial responsibilities are a form of professional recognition typically granted to well-established researchers. His record of supervising graduate and postgraduate students also reflects academic confidence in his mentorship and leadership. While formal awards could be added to enhance visibility, Dr. Solgi’s contributions, impact, and peer acknowledgment position him as a highly respected figure in his field.

Conclusion

Dr. Ghasem Solgi is a highly accomplished immunologist whose work bridges fundamental research and clinical application, particularly in the areas of transplantation immunology and immunogenetics. With an educational background grounded in top-tier Iranian institutions and complemented by international training, he has consistently demonstrated academic rigor and scientific curiosity. His professional roles across two leading Iranian universities, combined with his leadership of research labs and departments, reveal a strong commitment to advancing medical science and nurturing future experts. Dr. Solgi’s research has yielded valuable insights into the HLA system’s role in autoimmune diseases and transplant outcomes, contributing to the development of more effective diagnostic and therapeutic strategies. He possesses strong technical and analytical research skills, and his involvement in numerous peer-reviewed journals speaks to his academic credibility. Although additional international awards or collaborations would further elevate his profile, the depth and impact of his work firmly establish him as a deserving nominee for the Best Researcher Award. Dr. Solgi’s enduring contributions to immunology, combined with his leadership and mentorship, make him a vital asset to both the academic community and the broader field of clinical research.

Publications Top Notes

  1. Chemical Contamination in the Extracted DNA Affects the Results of HLA Typing by the PCR-SSOP Method

  • Authors: A. Shirizadeh, M. Ebrahimpur, S. Soltani, G. Solgi

  • Journal: Molecular Biology Reports

  • Year: 2025

  • Citations: 2

  1. A Potential Link Between HLA-DRB1/DQB1 Alleles and Response to Treatment in Rheumatoid Arthritis Patients

  • Authors: A. Tahamoli-Roudsari, A. Rasouli-Saravani, Z. Basiri, M. Hajilooei, G. Solgi

  • Journal: International Journal of Immunogenetics

  • Year: 2025

  1. Potential Contribution of Gut Microbiota in the Development of Autoantibodies in T1D Children Carrying HLA-DRB1/DQB1 Risk Alleles: An Experimental and In Silico Analysis

  • Authors: A. Shirizadeh, Z. Razavi, V. Saeedi, J. Faradmal, G. Solgi

  • Journal: Immunogenetics

  • Year: 2024

  • Citations: 1

  1. MicroRNA -21 Expression as an Auxiliary Diagnostic Biomarker of Acute Brucellosis

  • Authors: M. Rezaeepoor, F. Keramat, S. Jourghasemi, M. Hajilooei, G. Solgi

  • Journal: Molecular Biology Reports

  • Year: 2024

  1. Peripheral Blood Mononuclear Cells Show Markers of Mitochondrial Dysfunction in Rheumatoid Arthritis

  • Authors: A. Abbasifard, G. Solgi, I. Khodadadi, H. Tayebinia, A. Fazaeli

  • Journal: Cell Biochemistry and Function

  • Year: 2024

  • Citations: 1

  1. Determination of HLA Class II Risk Alleles and Prediction of Self/Non-Self-Epitopes Contributing Hashimoto’s Thyroiditis in a Group of Iranian Patients

  • Authors: A. Shirizadeh, S. Borzouei, Z. Razavi, J. Faradmal, G. Solgi

  • Journal: Immunogenetics

  • Year: 2024

  1. Family-Based Association of HLA-DRB1 and DQB1 Alleles and Haplotypes in a Group of Iranian Type 1 Diabetes Children

  • Authors: A. Shirizadeh, Z. Razavi, V. Saeedi, G.E. Morahan, G. Solgi

  • Journal: HLA

  • Year: 2024

  • Citations: 3

  1. Epigenetic Regulation of FOXP3 Gene Expression in Relation to Impaired Function of Regulatory T Cells in Systemic Lupus Erythematosus

  • Authors: P. Fakour, A. Shirizadeh, A. Tahamoli-Roudsari, G. Solgi

  • Journal: Not specified

  • Citations: 1

 

Dhruvi Modi | microbiology | Best Researcher Award

Dr. Dhruvi Modi | microbiology | Best Researcher Award 

Research Coordinator at Albert Einstein College of Medicine, United States.

Dr. Dhruvi Modi, M.B.B.S., is a dedicated medical professional, certified by the ECFMG. She completed her M.B.B.S. from the Gujarat Adani Institute of Medical Sciences, Bhuj, India. Throughout her academic journey, Dr. Modi has gained experience through multiple internships and externships across prestigious medical institutions in India, the United States, and Canada. Notable for her contributions in the fields of cardiology, neurology, and infectious diseases, Dr. Modi is committed to expanding her expertise in healthcare. Currently, she is serving as an extern at Beaumont Medical Center and has gained recognition for her clinical skills and research contributions. She also contributes as an editor for Sudden Unexpected Death in Epilepsy books and reviews medical content for USMLE preparation. Dr. Modi aims to continuously enhance her knowledge and contribute meaningfully to the global medical community.

Profile

Education 🎓

Dr. Dhruvi Modi graduated with an M.B.B.S. degree from the Gujarat Adani Institute of Medical Sciences, Bhuj, India, in 2021. During her time there, she focused on acquiring a strong foundation in medicine and clinical practices. She completed her medical internship in various specialized departments at Gujarat Adani Institute and Surat Municipal Institute of Medical Education. Throughout her education, she developed a deep understanding of medical principles while engaging in clinical exposure and hands-on training. Dr. Modi also pursued multiple externships in institutions such as Beaumount Medical Center, Advent Health Orlando, and St. Mary Hospital in the United States, broadening her international exposure. These experiences provided her with diverse medical knowledge and a deep commitment to further education in the medical field, including ongoing training for USMLE exams and clinical shadowing.

Experience 💼

Dr. Dhruvi Modi has a robust background in clinical medicine, with experience in multiple prestigious medical settings. Her early experience included internships in India at Gujarat Adani Institute of Medical Sciences and Surat Municipal Institute of Medical Education, where she honed her skills in patient care, diagnosis, and treatment. Subsequently, she expanded her international medical expertise with externships at Beaumount Medical Center, Advent Health Orlando, and St. Mary Hospital in the United States, focusing on various specialties such as cardiology, neurology, and pulmonary medicine. Dr. Modi further enhanced her knowledge through externships in family medicine, emergency medicine, and cardiology, all while maintaining a strong academic record. Currently, she serves as an editor for books on Sudden Unexpected Death in Epilepsy and reviews content for USMLE preparation, showcasing her deep engagement with both medical practice and education.

Research Interests 🔬

Dr. Dhruvi Modi’s research interests primarily lie in cardiology, neurology, infectious diseases, and the impact of public health interventions. She has authored and contributed to several studies that investigate cardiovascular diseases, the effect of obesity on patient outcomes, and the relationship between body mass index and the prevalence of cardiovascular illnesses in the United States. Dr. Modi has shown a strong commitment to advancing knowledge in epidemiology, particularly through nationwide analysis and the application of artificial intelligence in predictive medical modeling. Her current research explores the effect of COVID-19 on hypertrophic cardiomyopathy and obesity in COVID-19 patients. Dr. Modi’s work aims to improve understanding of chronic diseases and contribute to better healthcare strategies globally, especially in underserved populations.

Awards 🏆

Dr. Dhruvi Modi’s dedication to medicine has earned her multiple accolades, including certifications and recognition for her performance in various fields. Her achievements include passing the USMLE Step 1 with a score of 236 and Step 2 with 235. She has been involved in numerous health initiatives, including UNICEF’s “Parvah” workshop and AMCON conferences, where she presented case reports on critical health topics. Dr. Modi’s commitment to community service is evident through her volunteer work with the WHO in Gujarat and participation in numerous health camps for underserved populations in India. She was also honored with opportunities to mentor students and conduct health checkups in collaboration with multiple medical organizations. These efforts underline her commitment to advancing healthcare and improving patient outcomes globally.

Publications 📚

Dr. Dhruvi Modi has contributed significantly to medical literature, with multiple published articles in prominent medical journals. Her most recent publication, titled “Prevalence of NAFLD and Associated Cardiovascular Events” (2023), was featured in the AGA Institute and presented at Digestive Day Week in Chicago. She has also authored articles on hypertrophic cardiomyopathy and the role of obesity in mortality among COVID-19 patients. Other notable works include her research on predictors of adverse cardiac and cerebrovascular events in inflammatory bowel disease, published in The American Journal of Gastroenterology (2023), and her systematic review on acute myocarditis, submitted to Cureus (2023). Dr. Modi’s research continues to be widely cited in medical journals, contributing to the growing body of knowledge in cardiology and public health.

  • Tu1603 Prevalence of NAFLD and Associated Cardiovascular Events and Prevailing Disparities in Otherwise Metabolically Healthy US Adults, 2019 National Inpatient Sample Analysis: A Paradox Effect
    Published: 2023
    Journal: AGA Institute Elsevier
    Volume: 164, Issue 6, Pages S-1054-S-1055
    Link: https://doi.org/10.1016/S00165085(23)03451-0
    Summary: This study analyzes the prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with cardiovascular events in metabolically healthy individuals in the US, highlighting a paradoxical effect of NAFLD in a generally healthy cohort.
  • Examining the Effect of COVID-19 on Hypertrophic Cardiomyopathy Hospitalizations in the USA: A Nationwide Propensity-Score Matched Analysis
    Published: November 9, 2023
    Journal: European Journal of Cardiology
    Link: https://doi.org/10.1093/eurheartj/ehad655.2
    Summary: This research investigates the impact of the COVID-19 pandemic on the hospitalization rates of hypertrophic cardiomyopathy patients in the United States, offering insights into healthcare system responses and patient outcomes during the pandemic.
  • Predictors of Major Adverse Cardiac and Cerebrovascular Events in Inflammatory Bowel Disease Using Artificial Neural Network Analysis in a Nationally Representative US Cohort
    Published: July 2023
    Journal: The American Journal of Gastroenterology
    Volume: 118(10S), Pages S669-S670
    Link: https://doi.org/10.14309/01.ajg.0000953236.08480.f1
    Summary: This study uses advanced artificial neural network models to predict the likelihood of major adverse cardiac and cerebrovascular events in patients with inflammatory bowel disease, providing valuable insights into the management of comorbidities in this patient group.

Conclusion

Dr. Dhruvi Modi exhibits exceptional promise as a researcher and clinician. Her robust background in medical internships, externships, and volunteer roles, along with her impressive publication record in well-known journals, makes her highly deserving of the Research for Best Researcher Award. Her work demonstrates a unique blend of clinical expertise and research capability, contributing to significant advances in various medical fields. With a slight increase in interdisciplinary research and expanded global collaborations, she has the potential to make even more groundbreaking contributions to healthcare research.

 

Taher Azimi | Microbioligy | Best Researcher Award

Assist Prof Dr. Taher Azimi | Microbioligy | Best Researcher Award

Faculty member at Shiraz University of Medical Sciences, Iran.

Dr. Taher Azimi is a prominent figure in the field of Environmental Science and Policy, with a diverse background in academia, government, and consultancy. He holds a Bachelor’s degree in Environmental Science and a Master’s degree in Environmental Policy. Dr. Azimi’s professional journey has seen him actively engaged in governmental initiatives, international collaborations, and private sector consulting, all aimed at addressing environmental challenges and promoting sustainable practices. His research interests span various aspects of environmental sustainability, making him a leading authority in shaping policies and practices for a more sustainable future.

Professional Profiles:

Education:

Dr. Taher Azimi completed his Bachelor’s degree in Environmental Science from an esteemed institution, followed by a Master’s degree in Environmental Policy from a renowned university.

Professional Experience

Dr. Taher Azimi began his professional journey by engaging in governmental initiatives aimed at addressing environmental challenges. He played a pivotal role in formulating and implementing policies related to sustainable development, biodiversity conservation, and climate change mitigation. Dr. Azimi’s expertise in environmental law and regulation led to significant contributions in drafting legislation aimed at protecting natural resources and promoting eco-friendly practices in industries. His career trajectory also includes collaborations with international organizations and non-profits dedicated to environmental advocacy. He participated in various projects and campaigns focused on raising awareness about environmental issues and mobilizing action for positive change. Additionally, Dr. Azimi has provided consulting services to private sector entities, offering strategic guidance on adopting environmentally responsible practices and compliance with regulatory standards.

Research Interests

Dr. Taher Azimi’s research interests encompass a wide range of topics within the field of Environmental Science and Policy. Some of his key areas of focus include sustainable development, biodiversity conservation, climate change mitigation and adaptation, environmental law and regulation, and corporate sustainability.

Publications

  1. Prevalence of antibiotic resistance in Escherichia coli strains simultaneously isolated from humans, animals, food, and the environment: a systematic review and …
    • Authors: A Pormohammad, MJ Nasiri, T Azimi
    • Year: 2019
    • Citations: 202
  2. Advanced strategies for combating bacterial biofilms
    • Authors: JY Sharahi, T Azimi, A Shariati, H Safari, MK Tehrani, A Hashemi
    • Year: 2019
    • Citations: 113
  3. Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis
    • Authors: A Pormohammad, K Mehdinejadiani, P Gholizadeh, MJ Nasiri, …
    • Year: 2020
    • Citations: 83
  4. Insertional inactivation of oprD in carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Tehran, Iran
    • Authors: A Shariati, T Azimi, A Ardebili, AS Chirani, A Bahramian, …
    • Year: 2018
    • Citations: 81
  5. Relationship of human herpes virus 6 and multiple sclerosis: a systematic review and meta‐analysis
    • Authors: A Pormohammad, T Azimi, F Falah, E Faghihloo
    • Year: 2018
    • Citations: 76
  6. Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review
    • Authors: T Azimi, M Mosadegh, MJ Nasiri, S Sabour, S Karimaei, A Nasser
    • Year: 2019
    • Citations: 72
  7. The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome
    • Authors: A Shariati, F Fallah, A Pormohammad, A Taghipour, H Safari, AS Chirani, …
    • Year: 2019
    • Citations: 69
  8. Evaluation of Nano-curcumin effects on expression levels of virulence genes and biofilm production of multidrug-resistant Pseudomonas aeruginosa isolated from …
    • Authors: A Shariati, E Asadian, F Fallah, T Azimi, A Hashemi, J Yasbolaghi Sharahi, …
    • Year: 2019
    • Citations: 68
  9. The role of bacteria in the inflammatory bowel disease development: a narrative review
    • Authors: T Azimi, MJ Nasiri, AS Chirani, R Pouriran, H Dabiri
    • Year: 2018
    • Citations: 67
  10. Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children’s Hospital, Tehran, Iran …
    • Authors: T Azimi, S Maham, F Fallah, L Azimi, Z Gholinejad
    • Year: 2019
    • Citations: 64